GLP-1
2 developments since Tue 10 Nov. Latest: Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug
- Developments
- 2
- Newsroom reports
- 2
Every development
2 developments since Tue 10 Nov.
- Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug
1 newsroom. Linked by GLP-1, weight, drug